Shenglan Gong

Point Mutation of the Proteasome β5 Subunit Gene Is an Important Mechanism of Bortezomib Resistance in Bortezomib-Selected Variants of Jurkat T Cell Lymphoblastic Lymphoma/Leukemia Line

Shuqing Lü, Jianmin Yang, Xianmin Song et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 106 citations

Overexpression of the PSMB5 gene contributes to bortezomib resistance in T-lymphoblastic lymphoma/leukemia cells derived from Jurkat line

Shuqing Lü, Zhilong Chen, Jianmin Yang et al. · Experimental Hematology · 2008 · 89 citations

Hematological Malignancy, T-lymphoblastic Lymphoma/leukemia Cells, Mixed-phenotype Acute Leukemia +9

Different mutants of PSMB5 confer varying bortezomib resistance in T lymphoblastic lymphoma/leukemia cells derived from the Jurkat cell line

Shuqing Lü, Jianmin Yang, Zhilong Chen et al. · Experimental Hematology · 2009 · 83 citations

Hematological Malignancy, Mixed-phenotype Acute Leukemia, Jurkat Cell Line +8

Radiation-induced lymphopenia correlates with survival in nasopharyngeal carcinoma: impact of treatment modality and the baseline lymphocyte count

Xiaoxue Xie, Shenglan Gong, Hekun Jin et al. · Radiation Oncology · 2020 · 46 citations · Full text

PIM-1 mRNA expression is a potential prognostic biomarker in acute myeloid leukemia

Hui Cheng, Chongmei Huang, Xiaoqian Xu et al. · Journal of Translational Medicine · 2017 · 23 citations · Full text